The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Department of Radiobiology, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
JAMA Netw Open. 2023 Mar 1;6(3):e231455. doi: 10.1001/jamanetworkopen.2023.1455.
Stroke is the leading cause of death in China. However, recent data about the up-to-date stroke burden in China are limited.
To investigate the urban-rural disparity of stroke burden in the Chinese adult population, including prevalence, incidence, and mortality rate, and disparities between urban and rural populations.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was based on a nationally representative survey that included 676 394 participants aged 40 years and older. It was conducted from July 2020 to December 2020 in 31 provinces in mainland China.
Primary outcome was self-reported stroke verified by trained neurologists during a face-to-face interviews using a standardized protocol. Stroke incidence were assessed by defining first-ever strokes that occurred during 1 year preceding the survey. Strokes causing death that occurred during the 1 year preceding the survey were considered as death cases.
The study included 676 394 Chinese adults (395 122 [58.4%] females; mean [SD] age, 59.7 [11.0] years). In 2020, the weighted prevalence, incidence, and mortality rates of stroke in China were 2.6% (95% CI, 2.6%-2.6%), 505.2 (95% CI, 488.5-522.0) per 100 000 person-years, and 343.4 (95% CI, 329.6-357.2) per 100 000 person-years, respectively. It was estimated that among the Chinese population aged 40 years and older in 2020, there were 3.4 (95% CI, 3.3-3.6) million incident cases of stroke, 17.8 (95% CI, 17.5-18.0) million prevalent cases of stroke, and 2.3 (95% CI, 2.2-2.4) million deaths from stroke. Ischemic stroke constituted 15.5 (95% CI, 15.2-15.6) million (86.8%) of all incident strokes in 2020, while intracerebral hemorrhage constituted 2.1 (95% CI, 2.1-2.1) million (11.9%) and subarachnoid hemorrhage constituted 0.2 (95% CI, 0.2-0.2) million (1.3%). The prevalence of stroke was higher in urban than in rural areas (2.7% [95% CI, 2.6%-2.7%] vs 2.5% [95% CI, 2.5%-2.6%]; P = .02), but the incidence rate (485.5 [95% CI, 462.8-508.3] vs 520.8 [95% CI, 496.3-545.2] per 100 000 person-years; P < .001) and mortality rate (309.9 [95% CI, 291.7-328.1] vs 369.7 [95% CI, 349.1-390.3] per 100 000 person-years; P < .001) were lower in urban areas than in rural areas. In 2020, the leading risk factor for stroke was hypertension (OR, 3.20 [95% CI, 3.09-3.32]).
In a large, nationally representative sample of adults aged 40 years or older, the estimated prevalence, incidence, and mortality rate of stroke in China in 2020 were 2.6%, 505.2 per 100 000 person-years, and 343.4 per 100 000 person-years, respectively, indicating the need for an improved stroke prevention strategy in the general Chinese population.
中风是中国的主要死亡原因。然而,最近关于中国当前中风负担的数据有限。
调查中国成年人口中风负担的城乡差异,包括患病率、发病率和死亡率,以及城乡人群之间的差异。
设计、地点和参与者:这是一项基于全国代表性调查的横断面研究,包括 676394 名年龄在 40 岁及以上的参与者。该研究于 2020 年 7 月至 12 月在中国大陆 31 个省进行。
主要结果是由经过培训的神经科医生在面对面访谈中使用标准化协议核实的自我报告的中风。通过定义在调查前 1 年内发生的首次中风来评估中风发病率。在调查前 1 年内导致死亡的中风被视为死亡病例。
该研究包括 676394 名中国成年人(395122 [58.4%] 名女性;平均[SD]年龄,59.7[11.0]岁)。2020 年,中国中风的加权患病率、发病率和死亡率分别为 2.6%(95%CI,2.6%-2.6%)、505.2(95%CI,488.5-522.0)/10 万人年和 343.4(95%CI,329.6-357.2)/10 万人年。据估计,2020 年中国 40 岁及以上人群中有 340 万例新发中风病例(95%CI,337-343),1780 万例现患中风病例(95%CI,175-180)和 230 万例中风死亡病例(95%CI,227-233)。2020 年,缺血性中风占所有新发中风病例的 15.5%(95%CI,15.2-15.6%),而脑出血占 2.1%(95%CI,2.1-2.1%),蛛网膜下腔出血占 0.2%(95%CI,0.2-0.2%)。与农村地区相比,城市地区的中风患病率较高(2.7%[95%CI,2.6%-2.7%]与 2.5%[95%CI,2.5%-2.6%];P=.02),但发病率(485.5[95%CI,462.8-508.3]与 520.8[95%CI,496.3-545.2]/10 万人年;P<.001)和死亡率(309.9[95%CI,291.7-328.1]与 369.7[95%CI,349.1-390.3]/10 万人年;P<.001)均较低。2020 年,中风的主要危险因素是高血压(OR,3.20[95%CI,3.09-3.32])。
在一项具有全国代表性的 40 岁及以上成年人大型样本中,2020 年中国中风的估计患病率、发病率和死亡率分别为 2.6%、505.2/10 万人年和 343.4/10 万人年,表明需要在普通中国人群中实施改进的中风预防策略。